Background Treatment of Polymyalgia rheumatica (PMR) is subject to wide variations in
clinical practice. We are currently developing new management guidelines for PMR for …

Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

Polymyalgia rheumatica is effectively treated with glucocorticoids. However, glucocorticoid
treatment can cause numerous and potentially serious side effects. Therefore, lowest …

To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia
rheumatica (PMR). A systematic literature review was conducted using Ovid Medline …

The 2010 BSR guidelines for the management of PMR [3] have been embellished by the
2015 EULAR ACR collaborative recommendations for the management of PMR by an …

Background One of the most frequent desires of patients with polymyalgia rheumatica (PMR)
is to individualize their treatment based on comorbidities, co-medication and prognostic …

Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease
in older people after rheumatoid arthritis. According to the 2015 EULAR-ACR …

Background: Polymyalgia rheumatica (PMR) is a debilitating, immune-mediated, chronic
inflammatory condition of unknown etiology. It is characterized by symmetrical pain and …

Glucocorticoids are the mainstay of treatment for patients with polymyalgia rheumatica
(PMR) and often produce substantial clinical improvements, but treatment can be …

Background: The diagnosis of polymyalgia rheumatica (PMR) requires the exclusion of
many inflammatory illnesses with arthralgia and myalgia in older people. Objectives: To …